You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

If data collection is expected to end later than planned, the companies should contact NICE to arrange an extension to the evidence generation period. NICE reserves the right to withdraw the guidance ...

This plan outlines the evidence gaps and what real-world data needs to be collected for a NICE review of the technologies again in the future. It is not a study protocol but suggests an approach to ...

NICE's medical technologies advisory committee considered evidence on 6 technologies for robot-assisted surgery for orthopaedic procedures from several sources. These include an early value assessment ...

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

Table 1 summarises the evidence gaps and the evidence available to the committee when the guidance was published. Information about evidence status is derived from the external assessment report.

The following considerations around implementing the evidence generation process have been identified through working with system partners.

Table 1 summarises the evidence gaps and ongoing studies that might address them. Information about evidence status is derived from the external assessment report. More information on the studies in ...

NICE's early value assessment of robot-assisted surgery for soft tissue procedures recommends that Da Vinci SP, Da Vinci X and Xi, Hugo robotic-assisted surgical system, Senhance Surgical System and ...